Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Inhibitory NK receptor recognition of HLA-G: regulation by contact residues and by cell specific expression at the fetal-maternal interface.

Gonen-Gross T, Goldman-Wohl D, Huppertz B, Lankry D, Greenfield C, Natanson-Yaron S, Hamani Y, Gilad R, Yagel S, Mandelboim O.

PLoS One. 2010 Jan 28;5(1):e8941. doi: 10.1371/journal.pone.0008941.

2.

Determinants of pancreatic beta-cell regeneration.

Khalaileh A, Gonen-Gross T, Magenheim J, Nir T, Porat S, Salpeter S, Stolovich-Rain M, Swisa A, Weinberg N, Dor Y.

Diabetes Obes Metab. 2008 Nov;10 Suppl 4:128-35. doi: 10.1111/j.1463-1326.2008.00948.x.

PMID:
18834440
3.

Intracellular cysteine residues in the tail of MHC class I proteins are crucial for extracellular recognition by leukocyte Ig-like receptor 1.

Gruda R, Achdout H, Stern-Ginossar N, Gazit R, Betser-Cohen G, Manaster I, Katz G, Gonen-Gross T, Tirosh B, Mandelboim O.

J Immunol. 2007 Sep 15;179(6):3655-61.

4.

HLA-G complexes are observed on the cell surface.

Gonen-Gross T, Mandelboim O.

Hum Immunol. 2007 Apr;68(4):227-32. Epub 2006 Nov 16.

PMID:
17400056
5.

Reduced KIR2DL1 recognition of MHC class I molecules presenting phosphorylated peptides.

Betser-Cohen G, Katz G, Gonen-Gross T, Stern N, Arnon TI, Achdout H, Gazit R, Mandelboim O.

J Immunol. 2006 Jun 1;176(11):6762-9.

6.

The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and beta 2-microglobulin-free HLA-G molecules.

Gonen-Gross T, Achdout H, Arnon TI, Gazit R, Stern N, Horejsí V, Goldman-Wohl D, Yagel S, Mandelboim O.

J Immunol. 2005 Oct 15;175(8):4866-74.

7.

Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus.

Arnon TI, Achdout H, Levi O, Markel G, Saleh N, Katz G, Gazit R, Gonen-Gross T, Hanna J, Nahari E, Porgador A, Honigman A, Plachter B, Mevorach D, Wolf DG, Mandelboim O.

Nat Immunol. 2005 May;6(5):515-23. Epub 2005 Apr 10.

PMID:
15821739
8.

Proteomic analysis of human natural killer cells: insights on new potential NK immune functions.

Hanna J, Fitchett J, Rowe T, Daniels M, Heller M, Gonen-Gross T, Manaster E, Cho SY, LaBarre MJ, Mandelboim O.

Mol Immunol. 2005 Feb;42(4):425-31.

PMID:
15607794
9.

Novel APC-like properties of human NK cells directly regulate T cell activation.

Hanna J, Gonen-Gross T, Fitchett J, Rowe T, Daniels M, Arnon TI, Gazit R, Joseph A, Schjetne KW, Steinle A, Porgador A, Mevorach D, Goldman-Wohl D, Yagel S, LaBarre MJ, Buckner JH, Mandelboim O.

J Clin Invest. 2004 Dec;114(11):1612-23. Retraction in: J Clin Invest. 2015 Apr;125(4):1763.

10.

MHC class I-independent recognition of NK-activating receptor KIR2DS4.

Katz G, Gazit R, Arnon TI, Gonen-Gross T, Tarcic G, Markel G, Gruda R, Achdout H, Drize O, Merims S, Mandelboim O.

J Immunol. 2004 Aug 1;173(3):1819-25.

11.

Biological function of the soluble CEACAM1 protein and implications in TAP2-deficient patients.

Markel G, Achdout H, Katz G, Ling KL, Salio M, Gruda R, Gazit R, Mizrahi S, Hanna J, Gonen-Gross T, Arnon TI, Lieberman N, Stren N, Nachmias B, Blumberg RS, Steuer G, Blau H, Cerundolo V, Mussaffi H, Mandelboim O.

Eur J Immunol. 2004 Aug;34(8):2138-48.

12.

Recognition of Mycoplasma hyorhinis by CD99-Fc molecule.

Gazit R, Rechnitzer H, Achdout H, Katzenell A, Katz G, Markel G, Arnon TI, Gonen-Gross T, Mizrahi S, Gruda R, Rottem S, Mandelboim O.

Eur J Immunol. 2004 Jul;34(7):2032-40.

13.

Expression of KIR2DL1 on the entire NK cell population: a possible novel immunodeficiency syndrome.

Gazit R, Garty BZ, Monselise Y, Hoffer V, Finkelstein Y, Markel G, Katz G, Hanna J, Achdout H, Gruda R, Gonen-Gross T, Mandelboim O.

Blood. 2004 Mar 1;103(5):1965-6. No abstract available.

14.

The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients.

Markel G, Mussaffi H, Ling KL, Salio M, Gadola S, Steuer G, Blau H, Achdout H, de Miguel M, Gonen-Gross T, Hanna J, Arnon TI, Qimron U, Volovitz I, Eisenbach L, Blumberg RS, Porgador A, Cerundolo V, Mandelboim O.

Blood. 2004 Mar 1;103(5):1770-8. Epub 2003 Nov 6. Erratum in: Blood. 2015 Mar 19;125(12):2006.

15.

Special organization of the HLA-G protein on the cell surface.

Gonen-Gross T, Gazit R, Achdout H, Hanna J, Mizrahi S, Markel G, Horejsí V, Mandelboim O.

Hum Immunol. 2003 Nov;64(11):1011-6.

PMID:
14602229
16.

The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46.

Arnon TI, Achdout H, Lieberman N, Gazit R, Gonen-Gross T, Katz G, Bar-Ilan A, Bloushtain N, Lev M, Joseph A, Kedar E, Porgador A, Mandelboim O.

Blood. 2004 Jan 15;103(2):664-72. Epub 2003 Sep 22.

17.

Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function.

Gonen-Gross T, Achdout H, Gazit R, Hanna J, Mizrahi S, Markel G, Goldman-Wohl D, Yagel S, Horejsí V, Levy O, Baniyash M, Mandelboim O.

J Immunol. 2003 Aug 1;171(3):1343-51.

18.

Enhanced recognition of human NK receptors after influenza virus infection.

Achdout H, Arnon TI, Markel G, Gonen-Gross T, Katz G, Lieberman N, Gazit R, Joseph A, Kedar E, Mandelboim O.

J Immunol. 2003 Jul 15;171(2):915-23.

Supplemental Content

Loading ...
Support Center